Skip to main content

Function

Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.

Involvement in disease

Melanoma, cutaneous malignant 3

CMM3

A malignant neoplasm of melanocytes, arising de novo or from a pre-existing benign nevus, which occurs most often in the skin but may also involve other sites.

None

Disease susceptibility is associated with variants affecting the gene represented in this entry.

Post-translational modifications

Phosphorylation at Thr-172 is required for enzymatic activity. Phosphorylated, in vitro, at this site by CCNH-CDK7, but, in vivo, appears to be phosphorylated by a proline-directed kinase. In the cyclin D-CDK4-CDKN1B complex, this phosphorylation and consequent CDK4 enzyme activity, is dependent on the tyrosine phosphorylation state of CDKN1B. Thus, in proliferating cells, CDK4 within the complex is phosphorylated on Thr-172 in the T-loop. In resting cells, phosphorylation on Thr-172 is prevented by the non-tyrosine-phosphorylated form of CDKN1B.

Sequence similarities

Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily.

Cellular localization

  • Cytoplasm
  • Nucleus
  • Nucleus membrane
  • Cytoplasmic when non-complexed. Forms a cyclin D-CDK4 complex in the cytoplasm as cells progress through G(1) phase. The complex accumulates on the nuclear membrane and enters the nucleus on transition from G(1) to S phase. Also present in nucleoli and heterochromatin lumps. Colocalizes with RB1 after release into the nucleus.

Alternative names

Cyclin-dependent kinase 4, Cell division protein kinase 4, PSK-J3, CDK4

Target type

Proteins

Primary research area

Oncology

Other research areas

  • Immuno-oncology

Molecular weight

33730Da

We found 22 products in 3 categories

Primary Antibodies

Proteins & Peptides

Cell Lines & Lysates

Target

Cell type

Species or organism

Search our catalogue for 'CDK4' (22)

Products

ab108357

Anti-Cdk4 antibody [EPR4513-32-7]

Recombinant
RabMAb
KO Validated
20ul selling size

ab108355

Anti-Cdk4 antibody [EPR4513-54-3]

Recombinant
RabMAb
KO Validated
20ul selling size

ab68266

Anti-Cdk4 antibody [EPR2513Y]

Recombinant
RabMAb
20ul selling size

ab213216

Anti-Cdk4 antibody [EPR4513-32-7] - BSA and Azide free

Recombinant
RabMAb
KO Validated

ab236042

Anti-Cdk4 antibody [EPR2513Y] - BSA and Azide free

Recombinant
RabMAb
KO Validated

ab247645

Anti-Cdk4 antibody [EPR4513-54-3] - BSA and Azide free

Recombinant
RabMAb
KO Validated

ab193968

HRP Anti-Cdk4 antibody [EPR4513-32-7] - Loading Control

Recombinant
RabMAb
KO Validated

ab214642

Alexa Fluor® 488 Anti-Cdk4 antibody [EPR2513Y]

Recombinant
RabMAb
KO Validated

ab193967

Alexa Fluor® 647 Anti-Cdk4 antibody [EPR4513-32-7]

Recombinant
RabMAb
KO Validated

ab255378

Human CDK4 knockout HeLa cell line

Advanced Validation

ab193966

Alexa Fluor® 488 Anti-Cdk4 antibody [EPR4513-32-7]

Recombinant
RabMAb
KO Validated

ab215318

Alexa Fluor® 555 Anti-Cdk4 antibody [EPR4513-32-7]

Recombinant
RabMAb
KO Validated

ab213664

PE Anti-Cdk4 antibody [EPR2513Y]

Recombinant
RabMAb